Research progress of oophorectomy in the combined modality therapy of colorectal cancer

doi:10.3877/cma.j.issn.2095-3224.2017.04.010

Abstract

Abstract:

Ovarian metastases are uncommon in women with colorectal cancer (CRC) and harbor poor prognosis. Due to less sensitivity to systemic chemotherapy of ovarian metastases compared to extraovarian metastases, oophorectomy in the comprehensive treatment of CRC deserves further study. This study reviewed researches on oophorectomy in the comprehensive treatment of CRC and summarized form two aspects including ovarian metastatectomy and prophylactic oophorectomy. Retrospective researches had shown potential survival benefits from optimal ovarian metastatectomy in CRC patients with ovarian metastasis, but randomized prospective trials are urgently warranted. Because of the low incidence of ovarian metastases from CRC, prophylactic oophorectomy in colorectal cancer surgery was not recommended by some researchers. However, strictly selected patients with clinical findings suggestive of ovarian micrometastasis might obtain survival benefits by prophylactic oophorectomy, which deserves further study.

Key words: Colorectal neoplasms, Therapy, Ovarian metastases, Oophorectomy

Qun Li, Jing Huang. Research progress of oophorectomy in the combined modality therapy of colorectal cancer[J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2017, 06(04): 316-319.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhjzcjbdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-3224.2017.04.010

https://zhjzcjbdzzz.cma-cmc.com.cn/EN/Y2017/V06/I04/316

References 26

[1]	Ribeiro Gomes J, Belotto M, D′Alpino Peixoto R. The role of surgery for unusual sites of metastases from colorectal cancer: A review of the literature[J]. Eur J Surg Oncol, 2017, 43(1):15-19.
[2]	Kanas GP, Taylor A, Primrose JN, et al. Survival after liver resection in metastatic colorectal cancer: review and meta-analysis of prognostic factors[J]. Clin Epidemiol, 2012, (4):283-301.
[3]	Gonzalez M, Poncet A, Combescure C, et al. Risk factors for survival after lung metastasectomy in colorectal cancer patients: a systematic review and meta-analysis[J]. Ann Surg Oncol, 2013, 20(2):572-579.
[4]	Segelman J, Flöter-Rådestad A, Hellborg H, et al. Epidemiology and prognosis of ovarian metastases in colorectal cancer[J]. Br J Surg, 2010, 97(11):1704-1709.
[5]	Tan KL, Tan WS, Lim JF, et al. Krukenberg tumors of colorectal origin: a dismal outcome—experience of a tertiary center[J]. Int J Colorectal Dis, 2010, 25(2):233-238.
[6]	Goéré D, Daveau C, Elias D, et al. The differential response to chemotherapy of ovarian metastases from colorectal carcinoma[J]. Eur J Surg Oncol, 2008, 34(12):1335–1339.
[7]	Taylor AE, Nicolson VM, Cunningham D. Ovarian metastases from primary gastrointestinal malignancies: the Royal Marsden Hospital experience and implications for adjuvant treatment[J]. Br J Cancer, 1995, 71(1):92–96.
[8]	Lee SJ, Lee J, Lim HY, et al. Survival benefit from ovarian metastatectomy in colorectal cancer patients with ovarian metastasis: a retrospective analysis[J]. Cancer Chemother Pharmacol, 2010, 66(2):229-235.
[9]	Chung TS, Chang HJ, Jung KH, et al. Role of surgery in the treatment of ovarian metastases from colorectal cancer[J]. J Surg Oncol, 2009, 100(7):570-574.
[10]	Rayson D, Bouttell E, Whiston F, et al. Outcome after ovarian/adnexal metastectomy in metastatic colorectal carcinoma[J]. J Surg Oncol, 2000, 75(3):186–192.
[11]	McCormick CC, Giuntili RL, Gardner GJ, et al. The role of cytoreductive surgery for colon cancer metastatic to the ovary[J]. Gynecol Oncol, 2007, 105(3):791–795.
[12]	Ayhan A, Guvenal T, Salman MC, et al. The role of cytoreductive surgery in nongenital cancers metastatic to the ovaries[J]. Gynecol Oncol, 2005, 98(2):235-241.
[13]	车旭，单毅，周志祥, 等. 结直肠癌卵巢转移的外科治疗及预后分析[J]. 中华肿瘤杂志, 2007, 29(11):864-866.
[14]	Sakakura C, Hagiwara A, Yamazaki J, et al. Management of postoperative follow-up and surgical treatment for Krukenberg tumor from colorectal cancers[J]. Hepatogastroenterology, 2004, 51(59):1350-1353.
[15]	Jiang R, Tang J, Cheng X, et al. Surgical treatment for patients with different origins of Krukenberg tumors: outcomes and prognostic factors[J]. Eur J Surg Oncol, 2009, 35(1):92-97.
[16]	Garrett CR, George B, Viswanathan C, et al. Survival benefit associated with surgical oophorectomy in patients with colorectal cancer metastatic to the ovary[J]. Clin Colorectal Canc, 2012, 11(3):191-194.
[17]	Birnkrant A, Sampson J, Sugarbaker PH. Ovarian metastasis from colorectal cancer[J]. Dis Colon Rectum, 1986, 29(11):767-771.
[18]	Mrad K, Marice P, Fabre A, et al. Krukenberg tumor: a clinico-pathological study of 15 cases[J]. Ann Pathol, 2000, 20(3):202-206.
[19]	Sielezneff I, Salle E, Antoine K, et al. Simultaneous bilateral oophorectomy does not improve prognosis of postmenopausal women undergoing colorectal resection for cancer[J]. Dis Colon Rectum, 1997, 40(11):1299-1302.
[20]	Tentes A, Markakidis S, Mirelis C, et al. Oophorectomy during surgery for colorectal carcinoma[J]. Tech Coloproctol, 2004(Suppl 1):s214-216.
[21]	Liang JT, Lai HS, Wu CT, et al. Laparoscopic prophylactic oophorectomy plus N3 lymphadenectomy for advanced rectosigmoid cancer[J]. Ann Surg Oncol, 2007, 14(7):1991-1999.
[22]	Graffner HO, Alm PO, Oscarson JE. Prophylactic oophorectomy in colorectal carcinoma[J]. Am J Surg, 1983, 146(2):233-235.
[23]	Young-Fadok TM, Wolff BG, Nivatvongs S, et al. Prophylactic oophorectomy in colorectal carcinoma: preliminary results of a randomized, prospective trial[J]. Dis Colon Rectum, 1998, 41(3):277-283.
[24]	MacKeigan JM, Ferguson JA. Prophylactic oophorectomy and colorectal cancer in premenopausal patients[J]. Dis Colon Rectum, 1979, 22(6):401-405.
[25]	Cutait R, Lesser ML, Enker WE. Prophylactic oophorectomy in surgery for large-bowel cancer[J]. Dis Colon Rectum, 1983, 26(1):6-11.
[26]	Omranipour R, Abasahl A. Ovarian metastases in colorectal cancer[J]. Int J Gynecol Cancer, 2009, 19(9):1524-1528.

Please choose a citation manager

Content to export